Literature DB >> 23388827

mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts.

Ning Dai1, Jan Christiansen, Finn C Nielsen, Joseph Avruch.   

Abstract

Lack of IGF2 in mice results in diminished embryonic growth due to diminished cell proliferation. Here we show that mouse embryonic fibroblasts lacking the RNA-binding protein IMP1 (IGF2 mRNA-binding protein 1) have defective splicing and translation of IGF2 mRNAs, markedly reduced IGF2 polypeptide production, and diminished proliferation. The proliferation of the IMP1-null fibroblasts can be restored to wild-type levels by IGF2 in vitro or by re-expression of IMP1, which corrects the defects in IGF2 RNA splicing and translation. The ability of IMP1 to correct these defects is dependent on IMP1 phosphorylation at Ser181, which is catalyzed cotranslationally by mTOR complex 2 (mTORC2). Phosphorylation strongly enhances IMP1 binding to the IGF2-leader 3 5' untranslated region, which is absolutely required to enable IGF2-leader 3 mRNA translational initiation by internal ribosomal entry. These findings uncover a new mechanism by which mTOR regulates organismal growth by promoting IGF2 production in the mouse embryo through mTORC2-catalyzed cotranslational IMP1/IMP3 phosphorylation. Inasmuch as TORC2 is activated by association with ribosomes, the present results indicate that mTORC2-catalyzed cotranslational protein phosphorylation is a core function of this complex.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23388827      PMCID: PMC3576515          DOI: 10.1101/gad.209130.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  29 in total

Review 1.  The gene structure of the insulin-like growth factor family.

Authors:  J S Sussenbach
Journal:  Prog Growth Factor Res       Date:  1989

Review 2.  Inhibitors of ribosome functions.

Authors:  S Pestka
Journal:  Annu Rev Microbiol       Date:  1971       Impact factor: 15.500

3.  Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin.

Authors:  B Favre; P Turowski; B A Hemmings
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

4.  The specificities of protein kinase inhibitors: an update.

Authors:  Jenny Bain; Hilary McLauchlan; Matthew Elliott; Philip Cohen
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

5.  A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.

Authors:  T M DeChiara; A Efstratiadis; E J Robertson
Journal:  Nature       Date:  1990-05-03       Impact factor: 49.962

6.  Influence of the four leader sequences of the human insulin-like-growth-factor-2 mRNAs on the expression of reporter genes.

Authors:  C H De Moor; M Jansen; E J Bonte; A A Thomas; J S Sussenbach; J L Van den Brande
Journal:  Eur J Biochem       Date:  1994-12-15

7.  Placental-specific IGF-II is a major modulator of placental and fetal growth.

Authors:  Miguel Constância; Myriam Hemberger; Jennifer Hughes; Wendy Dean; Anne Ferguson-Smith; Reinald Fundele; Francesca Stewart; Gavin Kelsey; Abigail Fowden; Colin Sibley; Wolf Reik
Journal:  Nature       Date:  2002-06-27       Impact factor: 49.962

8.  Discriminating translation of insulin-like growth factor-II (IGF-II) during mouse embryogenesis.

Authors:  S Newell; A Ward; C Graham
Journal:  Mol Reprod Dev       Date:  1994-11       Impact factor: 2.609

9.  Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway.

Authors:  F C Nielsen; L Ostergaard; J Nielsen; J Christiansen
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

10.  Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis.

Authors:  J E Lee; J Pintar; A Efstratiadis
Journal:  Development       Date:  1990-09       Impact factor: 6.868

View more
  38 in total

Review 1.  mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.

Authors:  Andras Perl
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

2.  Mammalian target of rapamycin complex 2 modulates αβTCR processing and surface expression during thymocyte development.

Authors:  Po-Chien Chou; Won Jun Oh; Chang-Chih Wu; Joseph Moloughney; Markus A Rüegg; Michael N Hall; Estela Jacinto; Guy Werlen
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

Review 3.  Making new contacts: the mTOR network in metabolism and signalling crosstalk.

Authors:  Mitsugu Shimobayashi; Michael N Hall
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

4.  IMP2 Increases Mouse Skeletal Muscle Mass and Voluntary Activity by Enhancing Autocrine Insulin-Like Growth Factor 2 Production and Optimizing Muscle Metabolism.

Authors:  Laura Regué; Fei Ji; Daniel Flicker; Dana Kramer; William Pierce; Teekhon Davidoff; Jeffrey J Widrick; Nicholas Houstis; Liliana Minichiello; Ning Dai; Joseph Avruch
Journal:  Mol Cell Biol       Date:  2019-03-19       Impact factor: 4.272

5.  IGF2BP2/IMP2-Deficient mice resist obesity through enhanced translation of Ucp1 mRNA and Other mRNAs encoding mitochondrial proteins.

Authors:  Ning Dai; Liping Zhao; Diedra Wrighting; Dana Krämer; Amit Majithia; Yanqun Wang; Valentin Cracan; Diego Borges-Rivera; Vamsi K Mootha; Matthias Nahrendorf; David R Thorburn; Liliana Minichiello; David Altshuler; Joseph Avruch
Journal:  Cell Metab       Date:  2015-04-07       Impact factor: 27.287

6.  Ras Suppresses TXNIP Expression by Restricting Ribosome Translocation.

Authors:  Zhizhou Ye; Donald E Ayer
Journal:  Mol Cell Biol       Date:  2018-09-28       Impact factor: 4.272

7.  Enhanced CLIP Uncovers IMP Protein-RNA Targets in Human Pluripotent Stem Cells Important for Cell Adhesion and Survival.

Authors:  Anne E Conway; Eric L Van Nostrand; Gabriel A Pratt; Stefan Aigner; Melissa L Wilbert; Balaji Sundararaman; Peter Freese; Nicole J Lambert; Shashank Sathe; Tiffany Y Liang; Anthony Essex; Severine Landais; Christopher B Burge; D Leanne Jones; Gene W Yeo
Journal:  Cell Rep       Date:  2016-04-07       Impact factor: 9.423

8.  Integrin alpha V beta 3 targeted dendrimer-rapamycin conjugate reduces fibroblast-mediated prostate tumor progression and metastasis.

Authors:  Elliott E Hill; Jin Koo Kim; Younghun Jung; Chris K Neeley; Kenneth J Pienta; Russell S Taichman; Jacques E Nor; James R Baker; Paul H Krebsbach
Journal:  J Cell Biochem       Date:  2018-06-22       Impact factor: 4.429

9.  Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner.

Authors:  Rachel Miloslavski; Elad Cohen; Adam Avraham; Yifat Iluz; Zvi Hayouka; Judith Kasir; Rajini Mudhasani; Stephen N Jones; Nadine Cybulski; Markus A Rüegg; Ola Larsson; Valentina Gandin; Arjuna Rajakumar; Ivan Topisirovic; Oded Meyuhas
Journal:  J Mol Cell Biol       Date:  2014-03-13       Impact factor: 6.216

10.  IGF2BP1 controls cell death and drug resistance in rhabdomyosarcomas by regulating translation of cIAP1.

Authors:  M D Faye; S T Beug; T E Graber; N Earl; X Xiang; B Wild; S Langlois; J Michaud; K N Cowan; R G Korneluk; M Holcik
Journal:  Oncogene       Date:  2014-04-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.